Retatrutide is an investigational once-weekly molecule developed to activate three hormone receptors: glucose-dependent insulinotropic polypeptide (GIP) receptors
These properties are important for groups that buy retatrutide peptide for advanced metabolic research
TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial nej.md/3JoNIh6 #ClinicalMedicine 2
"Your healthcare provider will determine the appropriate dosage for you based on how your blood sugar levels, how your body adjusts to the medication, and any side effects," notes Eapen, MD
For once-daily formulations like liraglutide (Victoza, Saxenda), the NHS advises taking the injection at approximately the same time each day
And we have a compound here that, as one of its main functions, really addresses precisely this